Advances in Vitamin D Therapeutics in CF Trang Le, M. D

Slides:



Advertisements
Similar presentations
{ Dose Response to Vitamin D Supplementation in Postmenopausal Women Annals of Internal Med. 2012; 156: Jayme Bristow.
Advertisements

Osteoporosis in IBD. General Risk Factors for Osteoporosis Advancing age Advancing age Female gender Female gender Family history Family history Alcohol.
How Should We Monitor, Prevent, and Treat Osteoporosis in IBD? All of Our IBD Patients are at Risk and Therefore all Should Begin Treatment at Diagnosis.
Epidemiology of vitamin D deficiency in children presenting to a paediatric outpatient service in the UK J M Reed, J H Davies, L Blake, A Jackson, N.
What is vitamin D? Vitamin D is classified as a fat soluble vitamin
Vitamin D Supplementation in Healthy Children and Adolescents SCH Journal Club Rachel Harrison 20 th September 2012.
Osteoporosis Dr. Aisha Sheikh FCPS (Pak), Fellowship Diabetes/Endocrinology (AKUH), PG Dip Diab (UK) Consultant Endocrinologist.
West Midlands Guidelines for managing CKD Mineral and Bone Disorders in Haemodialysis Patients
Calcium & phosphor disturbance CKD- MBD Dr. Atapour.
Downloaded from 1 Alendronate vs. Risedronate Comparison Trial.
Importance of calcium: Ca ++ regulates: Neural function Muscle contraction Secretion of some hormones Blood clotting.
New thoughts concerning optimal vitamin D levels in the US population December, 2008.
Case of the week Prof : Faiza Qari. T score of -2.5 in the lumbar spine  A 65 year old female was diagnosed to have osteoporosis (T score of -2.5 in.
Fortification with Vitamin D Edward Giovannucci, MD, ScD.
VITAMEN D DEFICIENCY IN SAUDI ARABIA THE SILENT EPIDEMIC
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J CLIN ENDOCRINOL METAB, 97, , 2012.
Vitamin D Analysis Noelle Pervere OHSU Dietetic Intern.
Effect of Vitamin D Supplementation on Serum 25-Hydroxyvitamin D Levels in Children with Chronic Disease Primary investigators: Tania Vander Meulen, MEd,
Lecture 7c 27 February ADEK ABSORPTION AND TRANSPORT carriers for both absorption and transport transport-lipoproteins in the blood.
What is vitamin D? Fat-soluble vitamin Produced when the sun reacts with a substance in the skin A massive 90 % is made by the skin and only 10% comes.
Vitamin D and cardiometabolic disorders  Recent data suggests a connection between vitamin D levels and cardiometabolic diseases: o Obesity o Impaired.
1 Ipriflavone in the Treatment of Postmenopausal Osteoporosis Randomized placebo-controlled, 4-year study conducted Europe 475 postmenopausal white women,
Materials and methods Design Open-label, randomized trial, February 2010 to May 2011, avoiding the summer period Participants recruited from a primary.
A High Prevalence of Vitamin D Inadequacy in a Minimal Trauma Fracture Population A High Prevalence of Vitamin D Inadequacy in a Minimal Trauma Fracture.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
What is the Bone?. Connective tissue  Organic matrix (cells & proteins)  Inorganic elements (calcium hydroxyapatite)
OSTEOPOROSIS IN SAUDI ARABIA ANOTHER EPIDEMIC WAITING TO HAPPEN ? MONA A FOUDA NEEL,MBBS, MRCP(UK),FRCPE MONA A FOUDA NEEL,MBBS, MRCP(UK),FRCPE ASSOCIATE.
Pathogenesis of Osteoporotic Fracture LOW PEAK BONE MASS LOW PEAK BONE MASS POSTMENOPAUSAL BONE LOSS POSTMENOPAUSAL BONE LOSS AGE-RELATED BONE LOSS.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
Vitamin D: Is It A Miracle Cure? Robert Coleman, M.D, F.A.C.E. Cotton-O'Neil Diabetes & Endocrinology Topeka, KS.
Vitamin D Status Relative to Diet, Lifestyle, Injury and Illness in College Athletes Tanya Halliday.
DR. MOHAMMED AL DUBAYEE, MD, MHSC, CDE ASSISTANT PROFESSOR, PEDIATRIC ENDOCRINOLOGIST KAMC- RIYADH VTI D BONE AND BEYOND ; WHEN TO SCREEN, WHOM TO TREAT?
Osteoporosis In Thalassemia Dr Tarek Jawad INT 555.
Weekly Alendronate Safe and Effective at Increasing Bone Mineral Density in HIV-Infected Persons on Antiretroviral Therapy Slideset on: McComsey GA, Kendall.
Moji Saberin-Williams, M.D. Paoli Hospital Obstetrician/Gynecologist
Osteoporosis Update DR. SYLVIE OUELLETTE RHEUMATOLOGIST.
Date of download: 9/17/2016 From: Dose Response to Vitamin D Supplementation in Postmenopausal Women: A Randomized Trial Ann Intern Med. 2012;156(6):
August 2012 An usual case 65 year old male Weakness, falling, no fracture History of coronary artery disease DXA scans: Lumbar Spine BMD T = -2.3; Total.
Treatment of Vitamin D Insufficiency in Postmenopausal Women: A randomized clinical trial Journal Club 1/8/2016 Sharda Mukunda.
Dept. Paediatrics, Leicester Royal Infirmary, Leicester
Vitamin D deficiency In Saudi Arabia
Vitamin D and HIV Subbulaxmi Trikudanathan, MD, MRCP, MMSc
Vitamin D Inadequacy is Highly Prevalent Among North American Women Treated for Osteoporosis MF Holick1, ES Siris2, N Binkley3, MK Beard4, AA Khan5, JT.
Osteopenia in Sheehan’s Syndrome
Correspondence: Efficacy of daily 800 IU vitamin D supplementation in reaching vitamin D sufficiency in nursing home residents:cross-sectional.
Therapeutic Implications
Recurrent falls in an older woman with diabetes
A daily 5000IU vs. weekly 50,000IU Vitamin D supplementation to Vitamin D deficient obese children: a head to head comparison Deborah Preston and Yoram.
In Cystic Fibrosis Patients Receiving Pancreatic Enzymes
Response to standard Vitamin D treatment among Children with Chronic Kidney Disease and Primary Hypertension Bandana Paudyal, MD, Gail Prado MD, Morris.
Department of Pediatric Newborn Medicine
Instructions for Using These Slide Templates
Goal-directed Treatment for Osteoporosis
Carlye Tomczyk, APRN, CNP University of Minnesota
Introduction Case Description Discussion
Dietary Consideration in Podiatric Practice
High Prevalence of Vitamin D Inadequacy and Implications for Health
Vitamin D Status of Black and White Americans and Changes in Vitamin D Metabolites after Varied Doses of Vitamin D Supplementation Naweed Alzaman1, Bess.
Case for androgens Giorgio Arnaldi Clinica di Endocrinologia
The What, Why and When? of Annual Studies
Intern Seminar: Vitamin D deficiency
High Prevalence of Vitamin D Inadequacy and Implications for Health
2010 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada Papaioannou A, et al. CMAJ 2010 Oct 12. [Epub ahead of print].
RAC-OST-POL Study population based Polish epidemiological study on postmenopausal osteoporosis prof. dr hab. n. med. Wojciech Pluskiewicz Medical University.
Deciding on Pharmacological Treatment Post Fracture
Deciding on Pharmacological Treatment Post Fracture
Protein for Healthy Bones
Serum Vitamin C (mg/dl) by Salad Intake
Lecture 7c 21 October 2016.
Presentation transcript:

Advances in Vitamin D Therapeutics in CF Trang Le, M. D Advances in Vitamin D Therapeutics in CF Trang Le, M.D. Virginia Commonwealth University / Children’s Hospital of Richmond Richmond, VA

Presenter Disclosure Trang Le, M.D. There are no relationships to disclose related to this presentation.

Objectives Summarize the relationship between vitamin D and cystic fibrosis (CF) health status Discuss differences between vitamin D formulations Review recent data on alternative vitamin D treatment options and strategies

Case A 23 year old African American woman with CF is seen for routine follow up of CF-related diabetes. She has been on ergocalciferol (D2), 50,000IU weekly for the preceding 6 months. She has no history of fractures. Menarche was at age 13 years, and she is on contraception with depot medroxyprogesterone.

Case D2 was increased to twice weekly, then three times weekly. 25-hydroxyvitamin D [25(OH)D] levels improved from 8.6 to 16.0 ng/mL. She also takes a calcium + vitamin D supplement with meals. Regarding diabetes, her A1c typically ranges 9-11%.

Case Bone mineral density (BMD) results (Z-scores): L-spine -0.9 Total hip -0.3 Femoral neck -0.9 Serum calcium and creatinine are normal How to get this patient to goal 25(OH)D ≥ 30 ng/mL?

Vitamin D in CF Vitamin D deficiency 25(OH)D level <20ng/mL or insufficiency (<30ng/mL) affects 90% of patients with CF Risk factors include: Pancreatic insufficiency malabsorption of fat-soluble vitamins Insufficient sunlight exposure Inadequate nutritional intake Rovner AJ, et al. Am J Clin Nutr. 2007;86(6):1694-1699

Lower Vitamin D levels are associated with lower bone density in CF Bone Mineral Density (g/cm2) 25(OH)D ≤ 10 ng/mL 25(OH)D>10ng/mL L-spine Total Hip Femoral Radius Figure 3. Bone mineral density of the lumbar spine, total hip, femoral neck, and the proximal radius in patients with low serum concentrationsof 25-hydroxyvitamin D (< 10 ng/dl; black bars) and those with borderline or normal serum concentrations of 25-hydroxyvitamin D (> 10 ng/dl; white bars) Donovan DS Jr. et al., Am J Repir Crit Care Med. 1998 Jun;157(6 Pt 1):1892-9.

Vitamin D independently predicts low BMD n=103 (adults + adolescents) Osteoporosis in 9.7%, osteopenia in 35% BMI, gender, weight, FEV1, and 25(OH)D levels were significantly correlated with Z-scores Model r Adusted r2 r2 change Beta F p 1 %FEV1 0.734 0.132 0.271 16.470 <0.001 2 Gender 0.494 0.229 0.104 -0.477 16.158 3 Weight 0.581 0.318 0.094 0.364 116.846 4 25(OH)D 0.608 0.344 0.032 -0.180 15.157 Stepwise regression analysis of demographic and clinical variables that best predict bone density Z-scores. Sheikh S. et al., J Bone Miner Metab, 2015 Mar;33(2):180-5

Vitamin D status is related to lung function 25(OH)D (nmol/L) FEV1 (% predicted) R2 = 0.30, P < 0.001, controlling for age, gender, BMI and race Wolfenden LL et al, Clin Endocrinol (Oxf) 2008, Sep;69(3)374-81

Vitamin D formulations Two main forms of oral supplementation : Vitamin D2 (ergocalciferol) Vitamin D3 (cholecalciferol) Only 5% of CF patients achieved vitamin D sufficiency with the 2005 CF Foundation recommendations for D2 Boyle MP, et al. Am J Respir Crit Care Med. 2005 Jul 15;172(2):212-7.

Randomized controlled trial, D2 vs D3 p Initial 25(OH)D, ng/mL 21.2 ± 10.18 24.4 ± 10.3 0.8 Final 25(OH)D, ng/dL 47.1 ± 20.5 32.7 ± 9.7 0.03 % sufficient (>30ng/mL) Initial (%) 22 40 0.09 Final (%) 100 60 0.003 D3 (50,000IU weekly) vs D2 (50,000IU weekly), 12 weeks 100% of the D3-treated patients achieved goal 25(OH)D levels ≥ 30ng/ml, vs 60% of the D2-treated patients Khazai NB, et al. J Clin Endocrinol Metab. 2009;94(6):2037-2043

D2 twice weekly vs D3 once weekly n=47, aged 6 - 21 years doubled frequency of D2 resulted in 69% of subjects reaching goal 25(OH) D2, vs 62% on D3, p = 0.59 Simoneau T, et al. J Cyst Fibros. 2016;15(2):234-241

D3 vehicle Fat malabsorption is a cardinal feature of CF with pancreatic insufficiency How does the vehicle in which vitamin D supplements are prepared influence the effect on serum vitamin D levels?

Oil vs powder D3 formulations D3 given as 100,000IU bolus, n=15 subjects: D3 given as 100,000IU D3 bolus, serum D3 and 25(OH)D levels were higher at 12 hours for subjects given D3 in powder-based rather than oil-based vehicle. Hermes WA, et al. JPEN J Parenter Enteral Nutr. 2016 Feb 22.

Single High Dose D3 (Stoss Therapy) 25(OH)D nmol/L, (ng/mL) <3 years 3-12 years >12 years ≤25 nmol/L (10) 200,000IU 400,000IU 600,000IU 25-50 (10-20) 150,000IU 350,000IU 500,000IU 50-75 (20-30) 100,000IU 300,000IU 0 1 3 6 12 Time (Months) 25(OH)D (nmol/L) 110 100 90 80 70 60 50 40 n=38 high dose, 37 controls no toxicity maintenance doses 0-2400IU D3 daily Administration of a very high single dose of oral D3 up to 600,000IU based on age and severity of 25(OH)D deficiency, followed by maintenance dosing n = 38 children received high-dose treatment; none of those who completed the 12 months of follow up experienced any vitamin D toxicity The stoss therapy group maintained better 25(OH)D levels than standard-treatment controls throughout the study: Shepherd D, et al. J Cyst Fibros. 2013;12(2):177-182

Calcitriol in CF Calcitriol administration was associated with: increased dietary calcium absorption decreased PTH decreased bone resorption N=10 CF, 10 controlls Brown SA, et al. Osteoporos Int. 2003;14(5):442-449.

Ultraviolet (UV) lamps UV lamps (such as those used for tanning) emitting UVB radiation stimulate vitamin D production in the skin May help to circumvent any CF-related malabsorption of oral Vitamin D

Case series: Treatment of vitamin D deficiency with UV light in patients with malabsorption syndromes n = 8 subjects with CF UV exposure to lower backs in a seated position for 5–10 min (depending on the skin type) 5 exposures per week for 8 weeks 29 27 25 23 Mean 25(OH)D 21 19 17 15 0 week 8 week Chandra P et al. Photodermatol Photoimmunol Photomed. 2007;23(5):179-185.

UV lamps up to 10 minutes of whole-body UV exposure, 1-3 times per week during the fall and winter significant  in 25(OH) D levels in the treatment group when compared with controls, 9 of 15 patients completed the 6 month study 70 60 25 (OH)D ng/mL 50 40 30 20 10 Baseline 8w 16w 24w Gronowitz E. at al,Acta Paediatr. 2005;94(5):547-552

D2 vs D3 vs UV light UV D3 D2 p Initial 25(OH)D, ng/mL 22.6 ± 10.8 21.2 ± 10.18 24.4 ± 10.3 0.8 Final 25(OH)D, ng/dL 28.3 ± 9.2 47.1 ± 20.5 32.7 ± 9.7 0.03 % sufficient (>30ng/mL) Initial (%) 22 40 0.09 Final (%) 100 60 0.003 portable UV indoor tanning lamp for 3–10 min (depending on skin type) five times a week, to the lower back >50% of patients randomized to UV self-reported underusage UV treated group did not have a significant increase in 25(OH) D levels Khazai NB, et al. J Clin Endocrinol Metab. 2009;94(6):2037-2043

Back to our Case Patient was switched from D2 to D3, same dose of 50,000IU three times per week Repeat 25(OH)D level after 3 months on D3= 33ng/mL Recommend dietary / supplemental Ca intake for goal of 1200-1500mg daily Encourage weight bearing exercise Discussed with GYN and switched to OCPs after she had received ~ 3 years of depot medroxyprogesterone

2012 Guidelines

Summary Treat all individuals with with CF with D3 to maintain 25(OH)D level ≥ 30ng/ml Measure 25(OH)D annually, preferably at end of winter D3 is preferred over D2 Insufficient evidence for benefit of bolus vs daily supplementation, consider patient preference

Summary Use age-specific, stepwise increases for treating vitamin D deficiency and deciding on referral threshold Consider calcitriol only in consultation with an expert in vitamin D therapy Not enough evidence to recommend for or against UV lamps

Acknowledgements Cystic Fibrosis Foundation, Envision CF: Emerging Leaders in CF Endocrinology Program Mentor: Vin Tangpricha, MD PhD CF Center, Virginia Commonwealth University CF Center, Children’s Hospital of Richmond at VCU Thank you!